Abstract 9628: Reference Ranges for Three-Dimensional Right Ventricular Quantification Using Contemporary Vendor-Neutral Echocardiography Software in Healthy Adults
Abstract
Background: Three-dimensional transthoracic echocardiography (3D-TTE) may overcome geometric limitations of two-dimensional right ventricular (RV) assessment, but contemporary reference ranges across vendor-neutral software and scanner platforms remain incompletely defined. Methods: We prospectively studied 100 healthy adults undergoing protocolized TTE from January to July 2023. Participants were evenly stratified by sex, age group, and scanner platform. RV 3D datasets were analyzed with TomTec version 51.02 and EchoPAC version 206 to measure RV end-diastolic volume (RVEDV), end-systolic volume (RVESV), stroke volume, indexed volumes, and RV ejection fraction (RVEF). Lower and upper limits of normal were defined as the 5th and 95th percentiles. Reproducibility was assessed using intraclass correlation coefficients and standard error of measurement, and determinants of RV measurements were evaluated using linear mixed-model regression. Results: Mean age was 44±15 years, 50% were female, mean body surface area was 1.94±0.27 m 2 , and mean RVEF was 50% by TomTec and 49% by EchoPAC. For TomTec versus EchoPAC, mean RVEDV was 119 mL versus 110 mL, RVEDVi was 61 versus 57 mL/m 2 , RVESV was 60 versus 57 mL, RVESVi was 31 versus 30 mL/m 2 , and lower limit of normal for RVEF was 41% for both platforms. TomTec showed stronger reproducibility for most parameters, including inter-reader ICC/SEM for RVEDV of 0.97/8.0 versus 0.73/25.7 with EchoPAC. In multivariable analysis, EchoPAC yielded lower RVEDV and RVESV than TomTec, whereas Philips yielded higher RVEDV and RVESV than GE. Software and scanner platform were not significantly associated with RVEF. Higher frame rate and left ventricular ejection fraction were associated with lower RV volumes and higher RVEF, whereas age, sex, heart rate, blood pressure, and RV systolic pressure were not significant determinants. Conclusions: In healthy adults, 3D-TTE RV reference ranges vary by analytic software and scanner platform for RV volumes but not RVEF. These findings support careful platform-specific interpretation of 3D-RV volumes and highlight the need for external validation and standardization before broad clinical adoption.